Business Context and Reporting Period
Company: Blue Acquisition Corp. (BACC), a Cayman Islands exempted special purpose acquisition company (SPAC).
Reporting Period: Quarterly period ended March 31, 2025 (Inception: February 10, 2025).
Status: Pre-IPO formation phase. The company has not commenced operations and has not selected a business combination target. The filing covers the period from inception through the balance sheet date, with significant subsequent events occurring in June 2025.
Key Financial Metrics (As of March 31, 2025)
| Metric | Value |
|---|---|
| Revenue | $0 (No operations) |
| Net Loss | $(61,786) |
| Operating Expenses | $61,816 (Formation and G&A) |
| Cash and Cash Equivalents | $70,030 |
| Total Assets | $177,930 |
| Total Liabilities | $114,716 |
| Shareholders' Equity | $63,214 |
| Working Capital | $(19,686) (Deficiency) |
| Debt (Related Party) | $26,089 (Promissory Note) |
Material Changes and Subsequent Events
The financial statements reflect the pre-IPO period. Significant capital events occurred subsequent to the reporting period (March 31, 2025) but prior to the filing date:
- Initial Public Offering (IPO): Consummated on June 16, 2025. Sold 20,125,000 Units (including full over-allotment) at $10.00 per unit, generating gross proceeds of $201,250,000.
- Private Placement: Simultaneously sold 592,250 Private Placement Units to the Sponsor and underwriters for $5,922,500.
- Trust Account: $201,250,000 was deposited into a U.S.-based trust account.
- Debt Settlement: The related party promissory note balance increased to $193,236 by June 16, 2025, and was fully repaid with an overpayment of $10,321 recorded as a receivable.
- Share Capitalization: In May 2025, the company issued an additional 1,009,988 Class B ordinary shares, resulting in 7,069,913 founder shares outstanding.
Outlook, Risks, and Management Commentary
- Going Concern: Management has raised substantial doubt about the company's ability to continue as a going concern as of March 31, 2025, due to a working capital deficiency and reliance on the successful completion of the IPO.
- Internal Controls: The company identified a material weakness in internal controls over financial reporting as of March 31, 2025, citing a lack of properly designed and operating controls. A remediation plan is underway.
- Business Combination Timeline: The company has 21 months from the IPO closing (June 16, 2025) to consummate a business combination, or until March 16, 2027, subject to extension.
- Deferred Fees: Underwriters are entitled to a deferred fee of $7,043,750 (3.5% of gross proceeds) payable only upon completion of a business combination.
- Administrative Costs: The company pays $5,000 per month to the Sponsor for office space and administrative support, commencing on the IPO effective date.
Investor Verification Checklist
- Verify the status of the material weakness in internal controls and the progress of the remediation plan.
- Confirm the Trust Account balance and the specific investments held (U.S. Treasury obligations or money market funds).
- Review the over-allotment option exercise status (fully exercised in June 2025) and its impact on the forfeiture of up to 922,163 founder shares.
- Assess the liquidity position post-IPO, specifically the cash held outside the Trust Account available for working capital and transaction costs.
- Monitor the 21-month deadline for completing a business combination and any potential extension requests requiring shareholder approval.